170 related articles for article (PubMed ID: 10522271)
1. Characterization of urinary metabolites of a new benzofuroquinoline derivative, 3,9-bis(N,N-dimethylcarbamoyloxy)-5 H-benzofuro[3,2-c]-quinoline-6-one (KCA-098), in dogs.
Yamada T; Yamamoto A; Fujioka M; Miyagi M; Saito N; Imai I; Otagiri M
Pharmazie; 1999 Sep; 54(9):672-7. PubMed ID: 10522271
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate. 4th communication: metabolism in rats and dogs.
Hirota T; Nakamura A; Sugihara K; Morino A
Arzneimittelforschung; 1997 Feb; 47(2):175-81. PubMed ID: 9079237
[TBL] [Abstract][Full Text] [Related]
3. Metabolism of the antianxiety drug buspirone in human subjects.
Jajoo HK; Mayol RF; LaBudde JA; Blair IA
Drug Metab Dispos; 1989; 17(6):634-40. PubMed ID: 2575499
[TBL] [Abstract][Full Text] [Related]
4. Metabolism of the antianxiety drug buspirone in the rat.
Jajoo HK; Mayol RF; LaBudde JA; Blair IA
Drug Metab Dispos; 1989; 17(6):625-33. PubMed ID: 2575498
[TBL] [Abstract][Full Text] [Related]
5. Studies of metabolic pathways of trimebutine by simultaneous administration of trimebutine and its deuterium-labeled metabolite.
Miura Y; Chishima S; Takeyama S
Drug Metab Dispos; 1989; 17(4):455-62. PubMed ID: 2571489
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the metabolites of the antidepressant drug nefazodone in human urine and plasma.
Mayol RF; Cole CA; Luke GM; Colson KL; Kerns EH
Drug Metab Dispos; 1994; 22(2):304-11. PubMed ID: 8013286
[TBL] [Abstract][Full Text] [Related]
7. Metabolism, pharmacokinetics, and excretion of a cholesteryl ester transfer protein inhibitor, torcetrapib, in rats, monkeys, and mice: characterization of unusual and novel metabolites by high-resolution liquid chromatography-tandem mass spectrometry and 1H nuclear magnetic resonance.
Prakash C; Chen W; Rossulek M; Johnson K; Zhang C; O'Connell T; Potchoiba M; Dalvie D
Drug Metab Dispos; 2008 Oct; 36(10):2064-79. PubMed ID: 18653742
[TBL] [Abstract][Full Text] [Related]
8. [Polymorphism of 3,9-bis-(N,N-dimethylcarbamoyloxy)-5H-benzofuro[3,2- c]quinoline-6-one(KCA-098), a new benzofuroquinoline derivative].
Yamada T; Ikegami K; Toda M; Saito N; Iizuka K; Otagiri M
Yakugaku Zasshi; 1995 Dec; 115(12):978-84. PubMed ID: 8587037
[TBL] [Abstract][Full Text] [Related]
9. Identification of urinary metabolites of ecabapide in rat.
Fujimaki Y; Hosokami T; Ono K
Xenobiotica; 1995 May; 25(5):501-10. PubMed ID: 7571723
[TBL] [Abstract][Full Text] [Related]
10. Structure elucidation of three isomeric metabolites of SYN-2836, a novel antifungal agent, in dogs via liquid chromatography/mass spectrometry and liquid chromatography/tandem mass spectrometry methodologies.
Bu HZ; Poglod M; Micetich RG; Khan JK
J Mass Spectrom; 1999 Nov; 34(11):1185-94. PubMed ID: 10548812
[TBL] [Abstract][Full Text] [Related]
11. Metabolism of nilvadipine, a new dihydropyridine calcium antagonist, in rats and dogs.
Terashita S; Tokuma Y; Fujiwara T; Shiokawa Y; Okumura K; Noguchi H
Xenobiotica; 1987 Dec; 17(12):1415-25. PubMed ID: 3439192
[TBL] [Abstract][Full Text] [Related]
12. Characterization of two phase I metabolites of bendamustine in human liver microsomes and in cancer patients treated with bendamustine hydrochloride.
Teichert J; Baumann F; Chao Q; Franklin C; Bailey B; Hennig L; Caca K; Schoppmeyer K; Patzak U; Preiss R
Cancer Chemother Pharmacol; 2007 May; 59(6):759-70. PubMed ID: 16957931
[TBL] [Abstract][Full Text] [Related]
13. HPLC-NMR with severe column overloading: fast-track metabolite identification in urine and bile samples from rat and dog treated with [14C]-ZD6126.
Lenz EM; D'Souza RA; Jordan AC; King CD; Smith SM; Phillips PJ; McCormick AD; Roberts DW
J Pharm Biomed Anal; 2007 Feb; 43(3):1065-77. PubMed ID: 17030109
[TBL] [Abstract][Full Text] [Related]
14. Biotransformation of proterguride in the perfused rat liver.
Krause W; Düsterberg B; Jakobs U; Hoyer GA
Drug Metab Dispos; 1993; 21(2):203-8. PubMed ID: 8097686
[TBL] [Abstract][Full Text] [Related]
15. Identification of the main urinary metabolites of omeprazole after an oral dose to rats and dogs.
Hoffmann KJ
Drug Metab Dispos; 1986; 14(3):341-8. PubMed ID: 2872036
[TBL] [Abstract][Full Text] [Related]
16. Isolation and identification of urinary metabolites of porfiromycin in dogs and humans.
Lang W; Mao J; Doyle TW; Almassian B
Drug Metab Dispos; 2000 Aug; 28(8):899-904. PubMed ID: 10901698
[TBL] [Abstract][Full Text] [Related]
17. In vivo metabolism of [14C]ruboxistaurin in dogs, mice, and rats following oral administration and the structure determination of its metabolites by liquid chromatography/mass spectrometry and NMR spectroscopy.
Barbuch RJ; Campanale K; Hadden CE; Zmijewski M; Yi P; O'Bannon DD; Burkey JL; Kulanthaivel P
Drug Metab Dispos; 2006 Feb; 34(2):213-24. PubMed ID: 16258078
[TBL] [Abstract][Full Text] [Related]
18. Metabolic N-demethylation of 1,3-bis[[1-cycloheptyl-3-(p- dimethylaminophenyl)ureido]methyl]benzene dihydrochloride, a novel acyl-coenzyme A:cholesterol acyltransferase inhibitor.
Uchida T; Usui T; Teramura T; Watanabe T; Higuchi S
Drug Metab Dispos; 1993; 21(3):524-9. PubMed ID: 8100510
[TBL] [Abstract][Full Text] [Related]
19. Identification of talinolol metabolites in urine of man, dog, rat and mouse after oral administration by high-performance liquid chromatography-thermospray tandem mass spectrometry.
Schupke H; Hempel R; Eckardt R; Kronbach T
J Mass Spectrom; 1996 Dec; 31(12):1371-81. PubMed ID: 8990520
[TBL] [Abstract][Full Text] [Related]
20. Identification of efonidipine hydrochloride metabolites in rats.
Nakabeppu H; Nakajima A; Kamikawaji Y; Shinozaki Y
Arzneimittelforschung; 1995 Jul; 45(7):766-70. PubMed ID: 8573219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
